Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
769.450.1%
QQQ
717.500.2%
BTC/USD
79927.800.512%
DIA
532.880.22%
GLD
406.530.06%
TLT
82.240.04%

Emergent BioSolutions Inc

EBSNYSE
Trade with Public
Trade with Public
$6.21
-0.02-0.32%
At close: Sep 4, 5:00 PM EST
$6.10
-0.11-1.77%
After Hours: Sep 4, 5:15 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Emergent BioSolutions Analyst Price Targets

Wall Street analyst price targets and consensus rating for Emergent BioSolutions (EBS).

Price Target Range — 10 Quarters

Analyst Consensus — 4 Analysts

3Buy
1Sell
Consensus RatingBuy# Analysts4Avg. Consensus PT$14Upside to Avg. PT+121.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 21, 2026JP MorganJessica FyeReinstatesUnderweight—
Aug 10, 2026HC Wainwright & Co.Raghuram SelvarajuPT CutBuy$12→$10
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
JP Morgan Reinstates Underweight on Emergent BioSolutions

JP Morgan analyst Jessica Fye reinstates Emergent BioSolutions (NYSE:EBS) with a Underweight.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Emergent BioSolutions, Lowers Price Target to $10

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Emergent BioSolutions (NYSE:EBS) with a Buy and lowers the price target from $12 to $10.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Emergent BioSolutions, Lowers Price Target to $12

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Emergent BioSolutions (NYSE:EBS) with a Buy and lowers the price target from $15 to $12.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $15 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Emergent BioSolutions (NYSE:EBS) with a Buy and maintains $15 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $15 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Emergent BioSolutions (NYSE:EBS) with a Buy and maintains $15 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $15 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Emergent BioSolutions (NYSE:EBS) with a Buy and maintains $15 price target.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved